;wherein;R1 represents C1-4 alkoxy optionally substituted by one or more fluorine atoms;;R2 represents H or C1-6 alkoxy optionally substituted by one or more fluorine atoms;;R3 represents a 5- or 6-membered heterocyclic ring, the ring being optionally substituted;;R4 represents a 4-, 5-, 6-, or 7-membered heterocyclic ring, the ring being optionally fused to a benzene ring or a 5- or 6-membered heterocyclic ring, the ring system as a whole being optionally substituted;;X represents CH or N; and;L is absent,;or represents a cyclic group of formula Ia, ;or represents a chain of formula Ib, ;and pharmaceutically acceptable salts thereof, are useful in therapy, in particular in the treatment of benign prostatic hyperplasia."/> Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
首页> 外国专利> Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia

Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia

机译:喹啉和喹唑啉化合物可用于治疗,特别是在良性前列腺增生的治疗中

摘要

Compounds of formula I, ;wherein;R1 represents C1-4 alkoxy optionally substituted by one or more fluorine atoms;;R2 represents H or C1-6 alkoxy optionally substituted by one or more fluorine atoms;;R3 represents a 5- or 6-membered heterocyclic ring, the ring being optionally substituted;;R4 represents a 4-, 5-, 6-, or 7-membered heterocyclic ring, the ring being optionally fused to a benzene ring or a 5- or 6-membered heterocyclic ring, the ring system as a whole being optionally substituted;;X represents CH or N; and;L is absent,;or represents a cyclic group of formula Ia, ;or represents a chain of formula Ib, ;and pharmaceutically acceptable salts thereof, are useful in therapy, in particular in the treatment of benign prostatic hyperplasia.
机译:式I的化合物,<化学id =“ CHEM-US-00001”> <图像文件=“ US06169093-20010102-C00001.GIF” imgContent =“ undefined” imgFormat =“ GIF” /> ;其中; R 1 代表任选被一个或多个氟原子取代的C 1-4 烷氧基;; R 2 代表任选H或C 1-6 烷氧基被一个或多个氟原子取代;; R 3 代表5或6元杂环,该环是任选取代的;; R 4 代表4-, 5元,6元或7元杂环,所述环任选地稠合至苯环或5元或6元杂环,整个环系统任选地被取代;; X代表CH或N;和; L不存在;或代表式Ia的环状基团,<化学id =“ CHEM-US-00002”> <图像文件=“ US06169093-20010102-C00002.GIF” imgContent =“ undefined” imgFormat =“ GIF “ /> ExternalFileRef file =” US06169093-20010102-C00002.MOL“ id =” CHEMMOL-00002“ /> ;或表示式为Ib的链,<化学id =“ CHEM-US-00003”> <图像文件=“ US06169093-20010102-C00003.GIF” imgContent =“ undefined” imgFormat =“ GIF” /> ;以及药学上可接受的盐其在治疗中有用,特别是在良性前列腺增生的治疗中。

著录项

  • 公开/公告号US6169093B1

    专利类型

  • 公开/公告日2001-01-02

    原文格式PDF

  • 申请/专利权人 PFIZER INC.;

    申请/专利号US19990341228

  • 发明设计人 DAVID NATHAN ABRAHAM FOX;

    申请日1999-07-07

  • 分类号A61K315/17;C07D2397/20;

  • 国家 US

  • 入库时间 2022-08-22 01:05:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号